Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMade Tech Regulatory News (MTEC)

Share Price Information for Made Tech (MTEC)

Share Price is delayed by 15 minutes
Get Live Data
38.50    -0.75 (-1.91%)
Bid:
38.00
Ask:
39.00
Spread: 1.00 (2.632%)
Market Cap: £57.48m
MTEC Live PriceLast checked at - London Stock Exchange

Intraday Made Tech Share Chart

Trading Statement

10 Dec 2025 07:00

RNS Number : 9157K
Made Tech Group PLC
10 December 2025
 

 

10 December 2025

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

MADE TECH GROUP PLC

("Made Tech", the "Group" or the "Company")

 

FIRST HALF TRADING UPDATE

Trading significantly ahead of expectations

 

Made Tech, a leading provider of digital, data and technology services to the UK public sector, is pleased to announce a trading update for the 6 months ended 30 November 2025 ("H1 FY26").

 

Revenue for H1 FY26 was c.£27.7 million (H1 FY25: £21.8 million), representing a year-on-year increase of c.27% following good Sales Bookings1 momentum in the second half of FY25. 

 

Adjusted EBITDA2 for H1 is expected to be c.£2.4 million (H1 FY25: £1.8 million), c.33% up on the equivalent prior year period. This represents an increase in margin from 8.2% to c.8.7%, a result of operational efficiencies, offset by a higher than target contractor base.

 

Net cash as at 30 November 2025 was £11.9 million (FY25: £10.4 million; H1 FY25: £9.1 million), reflecting the continuing strong operating cash flow conversion of the business. Made Tech remains debt-free.

 

As at 30 November 2025 Contracted Backlog3 was c.£74.0 million (FY25: £92.2 million; H1 FY25: £80.8 million) which provides good contractual coverage for the remainder of FY26 and into FY27. Sales bookings for H1 FY26 were softer than the strong prior year performance but the Sales Booking pipeline remains very active with a number of opportunities expected to increase the Contracted Backlog position in H2.

 

As a result of the strong trading performance in the first half of the year, the Board now expects trading for FY26 to be significantly ahead of current market expectations4, with revenue expected to be c.10% higher and Adjusted EBITDA margins increasing, reflecting improved operational gearing. The Group looks forward to announcing its Interim results for the 6 month period ended 30 November 2025 in February 2026.

 

Rory MacDonald, Chief Executive Officer, commented: 

 

"The first half of 2026 has been an exceptionally strong period for both revenue and Adjusted EBITDA, building on the momentum seen in FY25. Robust cash generation has further improved our balance sheet position and the strategic optionality this provides. Our near-term focus remains on sales pipeline conversion and adding to our already solid Contracted Backlog position, giving us good visibility into FY27.

 

The UK Government has emphasised the significant role technology will play in delivering its priorities, and we believe the Group continues to be well-positioned to capitalise on these opportunities. Consequently, we remain optimistic and confident in our outlook."

 

 Notes:

 

 All financials are based on unaudited figures.

 

1

Sales Bookings represent the total value of sales contracts awarded in the Period, to be delivered in FY26-FY30. Net Sales Bookings includes the value of sales contracts previously recognised that lapsed during the Period.

2

Adjusted EBITDA has been adjusted for the exclusion of depreciation, amortisation, impairments, exceptional items and share-based payment charge.

3

Contracted Backlog is the value of contracted revenue that has not yet been recognised. 

4

Based on the latest published equity research, the Company understands current market consensus for the year ended 31 May 2026 (FY26) to be revenue of £50.1m, Adjusted EBITDA of £3.9m and cash of £13.1m, and for the year ended 31 May 2027 (FY27) to be revenue of £55.1m, Adjusted EBITDA of £4.4m and cash of £16.1m.

 

 Enquiries:

 

Made Tech Group plc

Rory MacDonald, CEO

Neil Elton, CFO

Email: investor-relations@madetech.com

Canaccord Genuity Limited (Nominated Adviser & Broker)

Simon Bridges / Harry Gooden / Andrew Potts / Elizabeth Halley-Stott

Tel: +44 (0) 20 7523 8000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDBBDDCDGDGUC
12
Date   Source Headline
1st May 20266:14 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSMade Tech awarded £19m contract with the GDS
26th Feb 20267:00 amRNSAppointment of Chief Financial Officer
26th Feb 20267:00 amRNSInterim Results
10th Dec 20257:00 amRNSTrading Statement
25th Nov 20251:00 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSGrant of LTIP and SAYE options
11th Nov 202512:22 pmRNSResult of AGM
27th Oct 20252:35 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSNotice of AGM
7th Oct 20257:00 amRNSDirectorate Change
24th Sep 20257:00 amRNSFinal Results
3rd Sep 20255:02 pmRNSHolding(s) in Company
5th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
17th Jul 20257:00 amRNSGrant of Awards / PDMR Dealings
26th Jun 20257:01 amRNSDirectorate Change
26th Jun 20257:00 amRNSFY25 Trading Update
8th May 20257:00 amRNS-RChange of Registered Office
7th Apr 20257:00 amRNSContract Wins
5th Feb 20257:00 amRNSHalf Year Results
23rd Jan 20257:00 amRNSNotice of Half Year Results
15th Jan 20257:00 amRNSNon-Executive Director Board Changes
26th Nov 20247:00 amRNSLaunch of 2024 SAYE Scheme & Grant of SAYE options
20th Nov 20242:11 pmRNSResult of AGM
20th Nov 20247:00 amRNSAGM Statement
21st Oct 20247:00 amRNSNotice of AGM & Posting of Annual Report
10th Oct 20247:00 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSAudited Final Results 2024
16th Sep 20247:00 amRNSNew contract with the Department for Education
27th Jun 20247:00 amRNSFull Year Trading Update
1st May 20241:19 pmRNSDirector Share Purchase
23rd Apr 20243:47 pmRNSTR-1
22nd Apr 20247:00 amRNSMade Tech awarded £19.5m new contract with DLUHC
29th Feb 20247:00 amRNSTR-1
26th Feb 20249:09 amRNSHalf Year Results
26th Feb 20247:00 amRNSHalf Year Results
1st Feb 20247:00 amRNSTrading Update and Notice of Results
9th Jan 20247:00 amRNSAppointment of new CFO and Board Changes
17th Nov 20232:48 pmRNSDirector Share Purchase
30th Oct 20237:00 amRNSExercise of options and PDMR Dealing
26th Oct 20231:33 pmRNSResult of AGM
20th Sep 20233:55 pmRNSNotice of AGM and Posting of Annual Report 2023
13th Sep 20237:00 amRNSAudited Final Results 2023
6th Sep 20237:00 amRNSNotice of Results and Online Presentations
16th Aug 20235:26 pmRNSTR-1
25th Jul 20232:43 pmRNSGrant of LTIP Awards
5th Jul 20237:00 amRNSDirector Share Purchase
19th Jun 202310:03 amRNSTR-1
26th May 202312:38 pmRNSHolding(s) in Company
5th May 202312:56 pmRNSTR-1
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.